280 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
POSTER SESSIONS
272
006
Identification of a novel candidate locus to
predict response effectiveness to lithium treatment
in Sardinian patients with bipolar disorder
Konstantinos Mitropoulos, Greece
Alexandros Kanterakis, Alessio Squassina, Donatella
Congiu, Giovanni Severino, Maria del Zompo, George
Potamias, Theodora Katsila, George P. Patrinos
007
Genome-wide association study of resting state
endophenotypic markers in schizophrenia
Jessica Martin, Germany
Anja Richter, Katja Brodmann, George Chahine,
Sergi Papiol, Oliver Gruber
008
Ubiquitin-dependent regulation of synaptic
function in schizophrenia: a human postmortem
brain study
Estefanía Eugui Anta, Spain
Ronan Lyne, Gemma Riquelme, Belén Ramos
009
A hypothesis driven molecular pathway analysis
stresses the neurodevelopmental rather than neuro-
degenerative impairment in cognition in a sample of
schizophrenic patients
Ellen Fischer, Denmark
Antonio Drago
010
Quantitative proteomic analysis in postmortem
cerebellum in chronic schizophrenia
América Vera Montecinos, Spain
Ricard Rodriguez-Mias, Judit Villen, Belen Ramos
011
Pilot study of specificity protein 1 and 4 in
peripheral blood molecular cells in postmenopausal
women with schizophrenia treated with raloxifene
Èlia Vila Andreu, Spain
Elena Huerta-Ramos, Christian Nuñez, Judith Usall,
Belen Ramos
012
Mitochondrial phenotyping and deep charac-
terisation in schizophrenia using a patient-based in
vitro model
Richard Wüst, Germany
Marie Estelle Bellet, Christine Bus, Manuela Kübler,
Joachim Taeger, Andreas Johannes Fallgatter, Christian
Plewnia, Julia Fitzgerald, Rejko Krüger
013
Whole-genome sequencing of monozygotic
twins discordant for schizophrenia indicates multiple
genetic risk factors for schizophrenia
Jinsong Tang, People's Republic of China
Yanhui Liao, Xiaogang Chen
014
Genetic polymorphisms of glutathione S-trans-
ferases and oxidative stress in schizophrenia
Fabio Borghi, Brazil
Angélica Lopes, Rafael Fernandes-Ferreira, Lorena
Forner, Thais Andreguetto, Camila Ovieira-Brancati,
Bruna Farina, Eduardo Alves de Almeida, Dorotéia Rossi
Silva Souza, Gerardo De Araújo Filho
015
Methylation rate of the dopamine transporter
gene (DAT): a possible biomarker for the course of
tics in Tourette Syndrome
Katja Kunert, Germany
Ann-Sophie Höing, Hansi Pathak, Alexandra Kotsiari,
Helge Frieling, Kirsten Müller-Vahl
016
Effects of STW 3-VI (St. John's wort) on hippo-
campal and microglia cells in vitro
Christiane Kolb, Germany
Johanna Hofmann, Anna Schwendler, Julian Hüther,
Gabriel A. Bonaterra, Andrea Cordes, Heba Abdel-Aziz,
Ralf Kinscherf
017
Suicide attempt in monozygotic twins
Freddy Vasquez, Peru
Ysela Nicolas, Sylvia Falconi
018
A case report on the tuberous sclerosis:
family manifestation
Maka Areshidze, Republic of Georgia
Lali Abesadze
P-31
Poster Session
13:30– 15:00
|
Hall Budapest
TOPIC 16:
Diagnostics and classification,
psychopathology, RDoC
Diagnostics and classification, psychopathology,
RDoC
Chair:
Jürgen Zielasek, Germany
001
Benefits and challenges of the application
of the international classification of functioning,
disability and health (ICF) in psychiatry and psycho-
therapy in the context of the future introduction of
the ICD-11
Pavel Ptyushkin, Switzerland
002
Schmid and the German origins of multi-axial
systems
Luis Streb, Brazil
003
A systematic review of the acceptability of
mental health assessment tools
Bennett Quinn, United Kingdom
004
Reinterpreting error-related negativity under
the aegis of RDoC
Rita Pasion, Portugal
Fernando Barbosa
005
MAC-1: development and testing of a ques-
tionnaire to measure mindfulness, acceptance and
commitment
Nina Schulze, Germany
Silja C. Reuter, Peter Tonn